PLRX Insider Trading

Insider Ownership Percentage: 6.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,750,244.82

Pliant Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Pliant Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pliant Therapeutics Share Price & Price History

Current Price: $26.05
Price Change: Price Decrease of -0.06 (-0.23%)
As of 03/23/2023 01:00 AM ET

This chart shows the closing price history over time for PLRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Pliant Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/3/2023Bernard CoulieCEOSell15,000$33.61$504,150.00240,112View SEC Filing Icon  
1/31/2023Bernard CoulieCEOSell15,000$34.92$523,800.00240,112View SEC Filing Icon  
1/26/2023Bernard CoulieCEOSell15,000$35.29$529,350.00240,112View SEC Filing Icon  
1/24/2023Bernard CoulieCEOSell15,000$30.89$463,350.0093,812View SEC Filing Icon  
1/23/2023Eric LefebvreInsiderSell67,500$34.48$2,327,400.0076,926View SEC Filing Icon  
1/23/2023Keith Lamont CummingsCFOSell30,000$35.00$1,050,000.0084,424View SEC Filing Icon  
1/23/2023Mike OuimetteGeneral CounselSell20,000$34.19$683,800.005,947View SEC Filing Icon  
1/9/2023Bernard CoulieCEOSell5,000$19.17$95,850.0093,812View SEC Filing Icon  
1/6/2023Bernard CoulieCEOSell15,000$19.04$285,600.0093,812View SEC Filing Icon  
1/3/2023Bernard CoulieCEOSell15,000$19.33$289,950.0093,812View SEC Filing Icon  
12/22/2022Mike OuimetteGeneral CounselSell2,928$19.38$56,744.645,947View SEC Filing Icon  
12/20/2022Bernard CoulieCEOSell34,212$19.10$653,449.2093,812View SEC Filing Icon  
12/20/2022Eric LefebvreInsiderSell10,887$19.10$207,941.70144,426View SEC Filing Icon  
12/20/2022Keith Lamont CummingsCFOSell9,643$19.10$184,181.3080,424View SEC Filing Icon  
12/20/2022Mike OuimetteGeneral CounselSell4,719$19.10$90,132.908,875View SEC Filing Icon  
10/25/2022Eric LefebvreInsiderSell5,000$25.05$125,250.00133,437View SEC Filing Icon  
9/12/2022Bernard CoulieCEOSell12,502$22.54$281,795.0859,273View SEC Filing Icon  
7/11/2022Bernard CoulieCEOSell15,000$22.50$337,500.0059,273View SEC Filing Icon  
7/11/2022Eric LefebvreInsiderSell3,000$20.00$60,000.00138,436View SEC Filing Icon  
6/18/2021Eric LefebvreInsiderSell12,500$28.87$360,875.00140,830View SEC Filing Icon  
6/14/2021Bernard CoulieCEOSell4,000$33.03$132,120.0054,840View SEC Filing Icon  
5/14/2021Bernard CoulieCEOSell3,500$28.64$100,240.0054,840View SEC Filing Icon  
4/14/2021Bernard CoulieCEOSell3,500$30.33$106,155.0054,840View SEC Filing Icon  
3/18/2021Eric LefebvreInsiderSell12,500$39.41$492,625.00150,715View SEC Filing Icon  
3/15/2021Bernard CoulieCEOSell3,500$38.52$134,820.0048,840View SEC Filing Icon  
1/14/2021Bernard CoulieCEOSell3,500$26.38$92,330.0048,840View SEC Filing Icon  
12/18/2020Eric LefebvreInsiderSell12,500$26.54$331,750.00167,792View SEC Filing Icon  
12/14/2020Bernard CoulieCEOSell3,500$27.37$95,795.0048,840View SEC Filing Icon  
12/1/2020Keith Lamont CummingsCFOSell18,734$30.00$562,020.0034,712View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Pliant Therapeutics (NASDAQ:PLRX)

97.52% of Pliant Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PLRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Pliant Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/24/2023Natixis98,600$1.91M0.0%N/A0.202%Search for SEC Filing on Google Icon
2/16/2023Alliancebernstein L.P.107,978$2.09M0.0%+1.2%0.221%Search for SEC Filing on Google Icon
2/16/2023Personal Capital Advisors Corp10,790$0.21M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/15/2023Silverarc Capital Management LLC217,503$4.20M1.2%+3.7%0.446%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board36,654$0.71M0.0%N/A0.075%Search for SEC Filing on Google Icon
2/15/2023Squarepoint Ops LLC28,845$0.56M0.0%-13.5%0.059%Search for SEC Filing on Google Icon
2/15/2023Legal & General Group Plc9,726$0.19M0.0%N/A0.020%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC206,731$4M0.0%+6.6%0.424%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley113,980$2.20M0.0%-46.7%0.234%Search for SEC Filing on Google Icon
2/15/2023Man Group plc11,348$0.22M0.0%-38.2%0.023%Search for SEC Filing on Google Icon
2/15/2023Eversept Partners LP137,423$2.66M0.2%-53.3%0.282%Search for SEC Filing on Google Icon
2/15/2023Fred Alger Management LLC20,051$0.39M0.0%-23.8%0.041%Search for SEC Filing on Google Icon
2/15/2023First Light Asset Management LLC1,057,881$20.45M1.9%+9.6%2.170%Search for SEC Filing on Google Icon
2/15/2023Alps Advisors Inc.33,073$0.64M0.0%N/A0.068%Search for SEC Filing on Google Icon
2/15/2023Atom Investors LP39,419$0.76M0.4%+73.7%0.081%Search for SEC Filing on Google Icon
2/15/2023Avidity Partners Management LP2,240,400$43.31M0.9%+13.1%4.595%Search for SEC Filing on Google Icon
2/14/2023Price T Rowe Associates Inc. MD1,205,734$23.31M0.0%-2.1%2.473%Search for SEC Filing on Google Icon
2/14/2023Marshall Wace LLP65,820$1.27M0.0%N/A0.135%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP217,445$4.20M0.0%-12.3%0.446%Search for SEC Filing on Google Icon
2/14/2023Granahan Investment Management LLC505,184$9.77M0.3%+32.6%1.036%Search for SEC Filing on Google Icon
2/13/2023Charles Schwab Investment Management Inc.172,656$3.34M0.0%+2.2%0.354%Search for SEC Filing on Google Icon
2/13/2023Deutsche Bank AG315,308$6.10M0.0%+2.2%0.647%Search for SEC Filing on Google Icon
2/13/2023Bessemer Group Inc.554,891$10.73M0.0%-5.8%1.138%Search for SEC Filing on Google Icon
2/13/2023Natixis50,000$0.97M0.0%N/A0.103%Search for SEC Filing on Google Icon
2/13/2023Boulder Hill Capital Management LP19,500$0.38M0.3%N/A0.040%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC26,515$0.51M0.0%+373.8%0.054%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC20,800$0.40M0.0%-77.9%0.043%Search for SEC Filing on Google Icon
2/13/2023ExodusPoint Capital Management LP41,225$0.80M0.0%N/A0.085%Search for SEC Filing on Google Icon
2/13/2023Credit Suisse AG33,467$0.65M0.0%N/A0.069%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC349,608$6.76M0.0%+6.6%0.717%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP20,259$0.39M0.0%-8.9%0.042%Search for SEC Filing on Google Icon
2/13/2023JPMorgan Chase & Co.14,959$0.29M0.0%-59.5%0.031%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE21,301$0.41M0.0%-69.7%0.044%Search for SEC Filing on Google Icon
2/10/2023Franklin Resources Inc.1,489,444$28.79M0.0%-0.2%3.055%Search for SEC Filing on Google Icon
2/10/2023Tekla Capital Management LLC35,233$0.68M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/10/2023Cheyne Capital Management UK LLP66,144$1.28M2.2%N/A0.136%Search for SEC Filing on Google Icon
2/10/2023Lord Abbett & CO. LLC500,788$9.68M0.0%+0.3%1.027%Search for SEC Filing on Google Icon
2/9/2023Landscape Capital Management L.L.C.25,129$0.49M0.1%N/A0.052%Search for SEC Filing on Google Icon
2/9/2023Jennison Associates LLC1,733,590$33.51M0.0%-0.4%3.555%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP143,967$2.78M0.0%+624.9%0.295%Search for SEC Filing on Google Icon
2/9/2023Monashee Investment Management LLC150,000$2.90M1.2%+50.0%0.308%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.25,495$0.49M0.0%+351.1%0.052%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG5,395$0.10M0.0%-18.3%0.011%Search for SEC Filing on Google Icon
2/8/2023Swiss National Bank88,100$1.70M0.0%N/A0.181%Search for SEC Filing on Google Icon
2/8/2023Russell Investments Group Ltd.183,009$3.54M0.0%-4.4%0.375%Search for SEC Filing on Google Icon
2/8/2023Arizona State Retirement System10,302$0.20M0.0%N/A0.021%Search for SEC Filing on Google Icon
2/7/2023Fernwood Investment Management LLC304,573$5.89M2.4%+36.7%0.625%Search for SEC Filing on Google Icon
2/1/2023Zurcher Kantonalbank Zurich Cantonalbank 6,225$0.12M0.0%N/A0.013%Search for SEC Filing on Google Icon
1/30/2023New York State Common Retirement Fund20,350$0.39M0.0%+4.4%0.042%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp35,114$0.73M0.0%+232.2%0.072%Search for SEC Filing on Google Icon
11/16/2022Balyasny Asset Management LLC14,586$0.31M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/16/2022Fred Alger Management LLC26,319$0.55M0.0%N/A0.054%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.106,671$2.23M0.0%N/A0.219%Search for SEC Filing on Google Icon
11/15/2022State Street Corp213,581$4.46M0.0%+149.9%0.438%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP100,600$2.10M0.0%+82.2%0.206%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP248,007$5.18M0.0%+1,671.5%0.509%Search for SEC Filing on Google Icon
11/15/2022Trexquant Investment LP36,620$0.77M0.0%+8.2%0.075%Search for SEC Filing on Google Icon
11/15/2022UNC Management Company Inc.50,201$1.05M0.6%N/A0.103%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.1,599,324$33.41M0.0%+51.9%3.280%Search for SEC Filing on Google Icon
11/15/2022Price T Rowe Associates Inc. MD1,231,844$25.73M0.0%N/A2.526%Search for SEC Filing on Google Icon
11/15/2022Quantamental Technologies LLC16,343$0.34M0.1%N/A0.034%Search for SEC Filing on Google Icon
11/15/2022Lord Abbett & CO. LLC499,533$10.44M0.0%+56.7%1.024%Search for SEC Filing on Google Icon
11/15/2022Federated Hermes Inc.79,732$1.67M0.0%-75.9%0.164%Search for SEC Filing on Google Icon
11/15/2022First Manhattan Co.370,200$7.73M0.0%+185,000.0%0.759%Search for SEC Filing on Google Icon
11/15/2022First Light Asset Management LLC965,114$20.16M2.0%+25.4%1.979%Search for SEC Filing on Google Icon
11/15/2022Bank of New York Mellon Corp35,114$0.73M0.0%+232.2%0.072%Search for SEC Filing on Google Icon
11/15/2022BlackRock Inc.1,369,120$28.60M0.0%+54.5%2.808%Search for SEC Filing on Google Icon
11/14/2022Royal Bank of Canada19,820$0.42M0.0%+7,268.0%0.041%Search for SEC Filing on Google Icon
11/14/2022Tudor Investment Corp Et Al23,976$0.50M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/14/2022Cormorant Asset Management LP782,788$16.35M1.1%+62.3%1.605%Search for SEC Filing on Google Icon
11/14/2022Cubist Systematic Strategies LLC102,635$2.14M0.0%+100.0%0.210%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC94,300$1.97M0.0%-10.3%0.193%Search for SEC Filing on Google Icon
11/14/2022Blackstone Inc.10,040$0.21M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC29,928$0.63M0.0%-72.4%0.061%Search for SEC Filing on Google Icon
11/14/2022VR Adviser LLC1,080,000$22.56M3.3%N/A2.215%Search for SEC Filing on Google Icon
11/14/2022AXA S.A.298,398$6.23M0.0%-11.2%0.612%Search for SEC Filing on Google Icon
11/14/2022Altium Capital Management LP215,000$4.49M1.6%N/A0.441%Search for SEC Filing on Google Icon
11/14/2022HarbourVest Partners LLC64,826$1.35M0.4%N/A0.133%Search for SEC Filing on Google Icon
11/10/2022Dimensional Fund Advisors LP19,861$0.42M0.0%+35.0%0.041%Search for SEC Filing on Google Icon
11/10/2022Tower Research Capital LLC TRC 5,412$0.11M0.0%+73.3%0.011%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG6,600$0.14M0.0%+86.6%0.014%Search for SEC Filing on Google Icon
11/9/2022Bessemer Group Inc.589,266$12.31M0.0%+9.7%1.210%Search for SEC Filing on Google Icon
11/9/2022Fernwood Investment Management LLC222,757$4.65M2.0%+5.0%0.458%Search for SEC Filing on Google Icon
11/8/2022Atom Investors LP22,697$0.47M0.2%N/A0.047%Search for SEC Filing on Google Icon
11/8/2022New York State Common Retirement Fund19,500$0.41M0.0%-29.4%0.040%Search for SEC Filing on Google Icon
11/7/2022TD Asset Management Inc.29,560$0.61M0.0%N/A0.061%Search for SEC Filing on Google Icon
11/7/2022Jump Financial LLC46,201$0.97M0.0%+42.2%0.095%Search for SEC Filing on Google Icon
11/4/2022Prudential Financial Inc.54,300$1.14M0.0%N/A0.112%Search for SEC Filing on Google Icon
11/4/2022Russell Investments Group Ltd.191,487$4M0.0%+572.4%0.393%Search for SEC Filing on Google Icon
11/3/2022TRV GP Iii LLC3,839,160$80.20M35.0%-34.3%7.886%Search for SEC Filing on Google Icon
11/3/2022The Manufacturers Life Insurance Company28,440$0.59M0.0%N/A0.058%Search for SEC Filing on Google Icon
11/3/2022Barclays PLC5,596$0.12M0.0%-51.8%0.011%Search for SEC Filing on Google Icon
11/1/2022Monashee Investment Management LLC100,000$2.09M0.8%N/A0.205%Search for SEC Filing on Google Icon
11/1/2022Jennison Associates LLC1,740,977$36.37M0.0%N/A3.576%Search for SEC Filing on Google Icon
10/28/2022Silverarc Capital Management LLC209,822$4.38M1.5%N/A0.431%Search for SEC Filing on Google Icon
10/19/2022Bond & Devick Financial Network Inc.110,160$2.30M1.9%-8.3%0.226%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.331,495$2.66M0.0%+25.0%0.681%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.431,224$3.45M0.0%+202.2%0.886%Search for SEC Filing on Google Icon
8/17/2022Salem Investment Counselors Inc.7,735$62K0.0%+14.5%0.016%Search for SEC Filing on Google Icon
8/16/2022Corton Capital Inc.15,747$0.13M0.1%N/A0.032%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Pliant Therapeutics logo
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Read More on Pliant Therapeutics

Today's Range

Now: $26.05
Low: $25.63
High: $26.67

50 Day Range

MA: $30.05
Low: $21.94
High: $36.26

52 Week Range

Now: $26.05
Low: $3.96
High: $36.64

Volume

456,178 shs

Average Volume

442,080 shs

Market Capitalization

$1.54 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.44

Who are the company insiders with the largest holdings of Pliant Therapeutics?

Pliant Therapeutics' top insider investors include:
  1. Bernard Coulie (CEO)
  2. Eric Lefebvre (Insider)
  3. Keith Lamont Cummings (CFO)
  4. Mike Ouimette (General Counsel)
  5. Matthew Dunnigan (CFO)
Learn More about top insider investors at Pliant Therapeutics.

Who are the major institutional investors of Pliant Therapeutics?

Pliant Therapeutics' top institutional investors include:
  1. Avidity Partners Management LP — 4.59%
  2. Jennison Associates LLC — 3.56%
  3. Franklin Resources Inc. — 3.05%
  4. Price T Rowe Associates Inc. MD — 2.47%
  5. First Light Asset Management LLC — 2.17%
  6. Bessemer Group Inc. — 1.14%
Learn More about top institutional investors of Pliant Therapeutics stock.

Which major investors are selling Pliant Therapeutics stock?

During the previous quarter, PLRX stock was sold by these institutional investors:
  1. Eversept Partners LP
  2. Morgan Stanley
  3. Renaissance Technologies LLC
  4. Bank of America Corp DE
  5. Bessemer Group Inc.
  6. Two Sigma Investments LP
  7. Price T Rowe Associates Inc. MD
  8. JPMorgan Chase & Co.
During the previous year, company insiders that have sold Pliant Therapeutics company stock include:
  1. Bernard Coulie (CEO)
  2. Eric Lefebvre (Insider)
  3. Keith Lamont Cummings (CFO)
  4. Mike Ouimette (General Counsel)
Learn More investors selling Pliant Therapeutics stock.

Which major investors are buying Pliant Therapeutics stock?

In the previous quarter, PLRX stock was bought by institutional investors including:
  1. Avidity Partners Management LP
  2. Dimensional Fund Advisors LP
  3. Granahan Investment Management LLC
  4. Natixis
  5. First Light Asset Management LLC
  6. Swiss National Bank
  7. Fernwood Investment Management LLC
  8. Cheyne Capital Management UK LLP